ES2043270T3 - Dispositivo distribuidor. - Google Patents

Dispositivo distribuidor.

Info

Publication number
ES2043270T3
ES2043270T3 ES90301617T ES90301617T ES2043270T3 ES 2043270 T3 ES2043270 T3 ES 2043270T3 ES 90301617 T ES90301617 T ES 90301617T ES 90301617 T ES90301617 T ES 90301617T ES 2043270 T3 ES2043270 T3 ES 2043270T3
Authority
ES
Spain
Prior art keywords
distributor device
inflated
disengage
capsule
exposure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301617T
Other languages
English (en)
Inventor
Mcneill
Abdul Rashid
Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898903566A external-priority patent/GB8903566D0/en
Priority claimed from GB898921155A external-priority patent/GB8921155D0/en
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Application granted granted Critical
Publication of ES2043270T3 publication Critical patent/ES2043270T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Molding Of Porous Articles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Eye Examination Apparatus (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Surgical Instruments (AREA)
  • Massaging Devices (AREA)

Abstract

Un dispositivo de liberación controlada, el cual comprende al menos un material activo, dicha cápsula está formada por al menos dos piezas interpenetradas, la pieza macho está fabricada de un material hinchable por el agua, el cual se hincha para desencajar la pieza hembra por exposición a un medio acuoso.
ES90301617T 1989-02-16 1990-02-15 Dispositivo distribuidor. Expired - Lifetime ES2043270T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898903566A GB8903566D0 (en) 1989-02-16 1989-02-16 Drug dispensing device
GB898921155A GB8921155D0 (en) 1989-09-19 1989-09-19 Drug dispensing device

Publications (1)

Publication Number Publication Date
ES2043270T3 true ES2043270T3 (es) 1993-12-16

Family

ID=26294964

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90301617T Expired - Lifetime ES2043270T3 (es) 1989-02-16 1990-02-15 Dispositivo distribuidor.

Country Status (18)

Country Link
EP (2) EP0384646B1 (es)
JP (1) JPH0818971B2 (es)
KR (1) KR0141473B1 (es)
AT (1) ATE90202T1 (es)
AU (1) AU629915B2 (es)
CA (1) CA2047738C (es)
DE (1) DE69001831T2 (es)
DK (1) DK0384646T3 (es)
ES (1) ES2043270T3 (es)
FI (1) FI913880A0 (es)
GB (1) GB2230442B (es)
HU (1) HU207940B (es)
IE (1) IE64761B1 (es)
NO (1) NO303618B1 (es)
NZ (1) NZ232561A (es)
PT (1) PT93170B (es)
RU (1) RU2104084C1 (es)
WO (1) WO1990009168A1 (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
GB9004702D0 (en) * 1990-03-02 1990-04-25 Polysystems Limited Dispensing device
US5474784A (en) * 1990-03-02 1995-12-12 British Technology Group Limited Dispensing device
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
AU652984B2 (en) * 1992-01-14 1994-09-15 Endo Pharmaceuticals Solutions Inc. Preparation of homogeneous hydrogel copolymers
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
GB9223146D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Vented capsule
GB9223148D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule cap
CA2156726C (en) * 1993-02-26 2000-10-17 Paula Denise Davis Bisacodyl dosage form
ATE234611T1 (de) * 1993-04-20 2003-04-15 Tsrl Inc Mehrstufiges arzneistoffabgabesystem
GB9320732D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled delivery of liquid
GB9320733D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled release device construction
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
GB9323261D0 (en) * 1993-11-11 1994-01-05 Scherer Corp R P Dispensing device
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
EP0758244B2 (en) 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
GB9718664D0 (en) 1997-09-04 1997-11-05 Scherer Corp R P Improvements in or relating to capsules
GB9724450D0 (en) * 1997-11-20 1998-01-14 Scherer Corp R P Delayed release device
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
EP1053752A1 (en) 1998-02-10 2000-11-22 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
EP1773293B1 (en) 2004-06-17 2015-04-15 Endo Pharmaceuticals Solutions Inc. Compositions and methods for treating central precocious puberty
EP2455072A1 (en) 2005-03-11 2012-05-23 Endo Pharmaceuticals Solutions Inc. Controlled release formulations of octreotide
PL1916995T5 (pl) 2005-07-29 2022-10-31 Stichting Groningen Centre For Drug Research Kontrolowany wartością ph impulsowy układ podawczy, sposoby przygotowania i zastosowanie
CN101583620B (zh) 2005-11-28 2016-08-17 马里纳斯医药公司 加奈索酮组合物及其制备和使用方法
CA2634139C (en) 2005-12-20 2015-06-23 Cenestra, Llc. Omega 3 fatty acid formulations
CN102488652B (zh) 2006-03-16 2014-06-18 特瑞斯制药股份有限公司 含有药物-离子交换树脂复合物的经修饰释放的制剂
WO2008062320A2 (en) 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Extended release formulations of a proton pump inhibitor
MX2009011641A (es) 2007-04-27 2010-03-04 Endo Pharmaceuticals Solutions Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.
UA104866C2 (uk) 2008-06-25 2014-03-25 Ендо Фармас'Ютікалз Солюшнз Інк. Імплантат октреотиду, який містить вивільняючу речовину
WO2009158412A2 (en) 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Sustained delivery of exenatide and other polypeptides
US20110311628A1 (en) 2009-03-09 2011-12-22 Council Of Scientific And Industrial Research Pulsatile release composition of therapeutic agent
US20170079962A1 (en) 2009-11-11 2017-03-23 Rapamycin Holdings, Llc Oral Rapamycin Preparation and Use for Stomatitus
US9731025B2 (en) 2010-08-20 2017-08-15 National University Corporation Tokyo Medical And Dental University Pharmaceutical composition for transcolonic absorption
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
DK3272342T3 (da) 2011-03-23 2021-06-07 Ironshore Pharmaceuticals & Dev Inc Fremgangsmåder og sammensætninger til behandling af opmærksomhedsforstyrrelse
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
PT2739270T (pt) * 2011-08-01 2020-04-02 Hb Biotechnologies Corp Cápsulas não digestíveis para a distribuição de materiais absorventes de fluido
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
BR112014016550A8 (pt) * 2012-01-04 2017-07-04 Wellesley Pharmaceuticals Llc formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma
EP3072510B1 (en) 2012-03-30 2019-05-08 Micelle BioPharma, Inc. Omega-3 fatty acid ester compositions
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
AU2014373683B2 (en) 2013-12-31 2020-05-07 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
CA3254279A1 (en) 2015-06-03 2025-03-18 Triastek, Inc. PHARMACEUTICAL FORMS AND RELATED USES
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
CA3023278C (en) * 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
KR20190107712A (ko) 2017-01-26 2019-09-20 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
GB2112370B (en) * 1981-09-04 1984-09-26 Ciba Geigy Ag Inhibition of scale formation and corrosion in aqueous systems
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills

Also Published As

Publication number Publication date
EP0384646A1 (en) 1990-08-29
FI913880A7 (fi) 1991-08-16
DE69001831T2 (de) 1993-09-16
HU902238D0 (en) 1991-11-28
KR920700617A (ko) 1992-08-10
GB9003503D0 (en) 1990-04-11
ATE90202T1 (de) 1993-06-15
AU629915B2 (en) 1992-10-15
HU207940B (en) 1993-07-28
DK0384646T3 (da) 1993-07-12
NO913081L (no) 1991-08-08
JPH0818971B2 (ja) 1996-02-28
AU5163290A (en) 1990-09-05
KR0141473B1 (en) 1998-06-01
NZ232561A (en) 1992-02-25
FI913880A0 (fi) 1991-08-16
GB2230442B (en) 1992-11-25
PT93170A (pt) 1990-08-31
EP0384646B1 (en) 1993-06-09
NO303618B1 (no) 1998-08-10
CA2047738A1 (en) 1990-08-17
HUT58509A (en) 1992-03-30
PT93170B (pt) 1996-12-31
NO913081D0 (no) 1991-08-08
IE900556L (en) 1990-08-16
IE64761B1 (en) 1995-09-06
GB2230442A (en) 1990-10-24
WO1990009168A1 (en) 1990-08-23
DE69001831D1 (de) 1993-07-15
EP0458887A1 (en) 1991-12-04
JPH04505004A (ja) 1992-09-03
CA2047738C (en) 2000-02-15
RU2104084C1 (ru) 1998-02-10

Similar Documents

Publication Publication Date Title
ES2043270T3 (es) Dispositivo distribuidor.
DK0427247T3 (da) Lægemiddel indeholdende R-alpha- lipoinsyre eller S-alphalipoinsyre som aktiv bestanddel
ES2159591T3 (es) Composicion de liberacion controlada.
PE62796A1 (es) Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiol
ES2111547T3 (es) Comprimido de liberacion prolongada.
ATE146674T1 (de) Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveau
DE19975054I2 (de) Kontrazeptives Implantat
ES2050070B1 (es) Procedimiento para la preparacion de una composicion destinada a la liberacion prolongada y controlada de una substancia peptidica.
ATE268178T1 (de) Stabile medizinische zusammenstellungen die 4,5- epoxymorphinanderivate enthalten
MX171968B (es) Sistema de liberacion de medicamento intraoral
CO5670360A2 (es) Dispositivo de retencion gastrico expandible
HN1998000144A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa.
DK0625355T3 (da) Tablet med forbedret biologisk tilgængelighed indeholdende dichlormethylenphosphonsyre som virksomt stof
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
WO2001082820A3 (en) Lingual arch developer
ES2176980T3 (es) Elevalizos.
ES2081476T3 (es) Uso de acidos grasos especificos en la fabricacion de un medicamento para su suministro por iontoforesis.
BR0203501A (pt) Formulações de multipartìculas biomoduladas
PT98416A (pt) Processo para a preparacao de um sistema matricial de silicone elastomerico autoadesivo destinado a administracao prolongada de piribedilo por via transcutanea
AR006565A1 (es) Suspensiones acuosas de beta-ciflutrina
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
BR0010521A (pt) Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação
BRPI0008197B8 (pt) microcápsulas para a liberação prolongada de fármacos
ES2062794T3 (es) Derivados de (alquiltio-3 propil)-3 benzotiazolina, su preparacion y los medicamentos que les contienen.
ES273314Y (es) Dispositivo para la diseminacion de una feromona degradable por radiacion ultravioleta.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 384646

Country of ref document: ES